These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 38834997)

  • 1. Survival benefits of postoperative radiotherapy in patients with cT
    Yang J; Zhao J; Chang H; Yan L; Zhang J; Liu H; Ning P
    BMC Womens Health; 2024 Jun; 24(1):324. PubMed ID: 38834997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Efficacy analysis of radiotherapy combined with surgery for locally advanced rectal mucinous adenocarcinoma: a retrospective study based on data of Surveillance, Epidemiology, and End results population].
    Zhang Y; Wang X; Chi P; Lin H; Lu X; Huang Y; Xu Z; Huang S; Sun Y; Ye D
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jan; 22(1):85-93. PubMed ID: 30703799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is neoadjuvant chemotherapy necessary for T2N0-1M0 hormone receptor-positive/HER2-negative breast cancer patients undergoing breast-conserving surgery?
    Liu D; Chang L; Hao Q; Ren X; Liu P; Liu X; Wei Y; Wang M; Wu H; Kang H; Lin S
    J Cancer Res Clin Oncol; 2024 May; 150(5):285. PubMed ID: 38814494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postoperative radiotherapy improves survival of patients with ypN2 non-small cell lung cancer after neoadjuvant chemotherapy followed by surgery - A propensity score matching study of the Surveillance, Epidemiology, and End Results database.
    Bao Y; Yang X; Men Y; Kang J; Sun X; Zhao M; Sun S; Yuan M; Ma Z; Hui Z
    Thorac Cancer; 2022 Feb; 13(3):404-411. PubMed ID: 34907665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant chemotherapy and survival outcomes in older women with HR+/HER2- breast cancer: a propensity score-matched retrospective cohort study using the SEER database.
    Ma X; Wu S; Zhang X; Chen N; Yang C; Yang C; Cao M; Du K; Liu Y
    BMJ Open; 2024 Mar; 14(3):e078782. PubMed ID: 38490656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. No survival benefit could be obtained from adjuvant radiotherapy in esophageal cancer treated with neoadjuvant chemotherapy followed by surgery: A SEER-based analysis.
    Zheng SY; Qi WX; Zhao SG; Chen JY
    Front Oncol; 2022; 12():897476. PubMed ID: 36185174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of postoperative radiotherapy for squamous cell cancer of the breast in a surveillance epidemiology and end results population-based study.
    Wu SG; Sun JY; Liu WM; Li FY; Lin HX; He ZY
    Oncotarget; 2016 Mar; 7(9):10684-93. PubMed ID: 26863453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparing survival outcomes between neoadjuvant and adjuvant chemotherapy within T2N1M0 stage hormone receptor-positive, HER2-negative breast cancer: a retrospective cohort study based on SEER database.
    Shang Y; Wang X; Liu Y; Cheng W; Duan Y; Fang Z; Liu J; Kong F; Wang T; Yu T; Hu A; Zhang J; Zhang H; Li M; Rong Z; Li Y; Shakila SS; Li X; Feng J; Ma F; Guo B
    Breast Cancer; 2024 Jul; 31(4):684-694. PubMed ID: 38643430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of adjuvant radiotherapy on overall survival and breast cancer-specific survival of patients with malignant phyllodes tumor of the breast in different age groups: a retrospective observational study based on SEER.
    Yang P; Zhang G; Zhang Y; Zhao W; Tang J; Zeng S; Lv X; Lv L
    Radiat Oncol; 2024 May; 19(1):59. PubMed ID: 38773616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival benefit and impact of adjuvant chemotherapy following systemic neoadjuvant chemotherapy in patients with resected pancreas ductal adenocarcinoma: a retrospective cohort study.
    Pu N; Wu W; Liu S; Xie Y; Yin H; Chen Q; He T; Xu Z; Wang W; Yu J; Liu L; Lou W
    Int J Surg; 2023 Oct; 109(10):3137-3146. PubMed ID: 37418574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of adjuvant radiotherapy in patients with malignant phyllodes tumor of the breast: a propensity-score matching analysis.
    Zhao W; Tian Q; Zhao A; Wang B; Yang J; Wang L; Zhang L; Dong D; Chen L; Yang J
    Breast Cancer; 2021 Jan; 28(1):110-118. PubMed ID: 32748225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant radiation therapy for older women with early-stage breast cancer: a propensity-matched SEER analysis.
    Wu N; Tan Q; Su X; Yuan Y; Hou L; Li J
    Clin Transl Oncol; 2023 Feb; 25(2):523-534. PubMed ID: 36227413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival benefit of surgery with postoperative radiotherapy in locally advanced cervical adenocarcinoma: a population-based analysis.
    Wang X; Lu X; Chen J; Yi H; Lan Q
    BMC Surg; 2023 Oct; 23(1):299. PubMed ID: 37789291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of postmastectomy radiotherapy in clinically node-positive, stage II-III breast cancer patients with pathological negative nodes after neoadjuvant chemotherapy: an analysis from the NCDB.
    Liu J; Mao K; Jiang S; Jiang W; Chen K; Kim BY; Liu Q; Jacobs LK
    Oncotarget; 2016 Apr; 7(17):24848-59. PubMed ID: 26709538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Risk-adapted postmastectomy radiotherapy based on local-regional recurrence for T1-2N1M0 breast Cancer].
    Li M; Wang SL; Fang H; Tang Y; Chen B; Qi SN; Song YW; Liu YP; Lu NN; Li N; Tang Y; Ren H; Jin J; Li YX
    Zhonghua Zhong Liu Za Zhi; 2017 Nov; 39(11):841-849. PubMed ID: 29151291
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of neoadjuvant radiotherapy on survival of non-metastatic pancreatic ductal adenocarcinoma: a SEER database analysis.
    Wang D; Liu C; Zhou Y; Yan T; Li C; Yang Q; Xu Y; Zhao L; Pei Q; Tan F; Güngör C; Li Y
    Radiat Oncol; 2020 May; 15(1):107. PubMed ID: 32404114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of Postmastectomy Radiotherapy After Neoadjuvant Chemotherapy in Breast Cancer Patients: A Study from the Japanese Breast Cancer Registry.
    Miyashita M; Niikura N; Kumamaru H; Miyata H; Iwamoto T; Kawai M; Anan K; Hayashi N; Aogi K; Ishida T; Masuoka H; Iijima K; Masuda S; Tsugawa K; Kinoshita T; Tsuda H; Nakamura S; Tokuda Y
    Ann Surg Oncol; 2019 Aug; 26(8):2475-2485. PubMed ID: 31102090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiotherapy and Male Breast Cancer: A Population-based Registry Analysis.
    Madden NA; Macdonald OK; Call JA; Schomas DA; Lee CM; Patel S
    Am J Clin Oncol; 2016 Oct; 39(5):458-62. PubMed ID: 24781343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of radiotherapy in pulmonary large cell neuroendocrine carcinoma: propensity score matching analysis.
    Cao L; Wu HF; Zhao L; Bai Y; Jiang ZL; Yang WJ; Liu SX
    J Radiat Res; 2020 Jul; 61(4):594-601. PubMed ID: 32567658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant chemotherapy could not bring survival benefit to HR-positive, HER2-negative, pT1b-c/N0-1/M0 invasive lobular carcinoma of the breast: a propensity score matching study based on SEER database.
    Hu G; Hu G; Zhang C; Lin X; Shan M; Yu Y; Lu Y; Niu R; Ye H; Wang C; Xu C
    BMC Cancer; 2020 Feb; 20(1):136. PubMed ID: 32085753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.